November 13, 2017November 13, 2017

Elagolix Improves Uterine Fibroid Symptoms with and Without Add-Back Therapy, Trials Show

News

AbbVie presented data from two Phase 2 clinical trials showing that elagolix, with or without add-back therapy, led to a rapid reduction of heavy menstrual bleeding compared to a placebo ... Read more

November 8, 2017November 8, 2017

Enrollment Complete in EDELWEISS Phase 2b Trial of OBE2109 for Endometriosis Pain

News

ObsEva announced the completion of patient enrollment in a Phase 2b clinical trial to evaluate OBE2109, an oral gonadotropin releasing hormone (GnRH) receptor antagonist, for the treatment of endometriosis-associated pain. The ... Read more